|
Originally published In Press as doi:10.1074/jbc.M005150200 on August 30, 2000
J. Biol. Chem., Vol. 275, Issue 48, 37672-37678, December 1, 2000
Dominant Negative MyD88 Proteins Inhibit
Interleukin-1 /Interferon- -mediated Induction of Nuclear
Factor B-dependent Nitrite Production and Apoptosis in
Cells*
Philippe
Dupraz ,
Sandra
Cottet ,
Fabienne
Hamburger,
Wanda
Dolci,
Emanuella
Felley-Bosco, and
Bernard
Thorens§
From the Institute of Pharmacology and Toxicology, University of
Lausanne, 27 Rue du Bugnon, 1005 Lausanne, Switzerland
Insulin-dependent diabetes
mellitus is an autoimmune disease in which pancreatic islet cells are destroyed by a combination of immunological and inflammatory
mechanisms. In particular, cytokine-induced production of nitric oxide
has been shown to correlate with cell apoptosis and/or inhibition
of insulin secretion. In the present study, we investigated whether the
interleukin (IL)-1 intracellular signal transduction pathway
could be blocked by overexpression of dominant negative forms of the
IL-1 receptor interacting protein MyD88. We show that
overexpression of the Toll domain or the lpr mutant of MyD88 in
Tc-Tet cells decreased nuclear factor B (NF- B)
activation upon IL-1 and IL-1 /interferon (IFN)- stimulation.
Inducible nitric oxide synthase mRNA accumulation and nitrite
production, which required the simultaneous presence of IL-1 and
IFN- , were also suppressed by ~70%, and these cells were more
resistant to cytokine-induced apoptosis as compared with parental
cells. The decrease in glucose-stimulated insulin secretion induced by
IL-1 and IFN- was however not prevented. This was because these
dysfunctions were induced by IFN- alone, which decreased cellular
insulin content and stimulated insulin exocytosis. These results
demonstrate that IL-1 is involved in inducible nitric oxide synthase
gene expression and induction of apoptosis in mouse cells but does
not contribute to impaired glucose-stimulated insulin secretion.
Furthermore, our data show that IL-1 cellular actions can be blocked
by expression of MyD88 dominant negative proteins and, finally, that
cytokine-induced cell secretory dysfunctions are due to the action
of IFN- .
*
This work was supported by Grants 31-46958.96 from the Swiss
National Science Foundation (to B. T.) and 31-49662.96 (to
E. F. B.). This work was also supported by Juvenile Diabetes
Foundation International Grant 4-1999-844 and Modex
Thérapeutiques.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Contributed equally to the work.
§
To whom correspondence should be addressed. Tel.: 021 692 53 90;
Fax: 021 692 53 55; E-mail: bthorens@ipharm.unil.ch.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman
Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation
Endocr. Rev.,
August 1, 2008;
29(5):
603 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Faigon-Soverna, F. G. Harmon, L. Storani, E. Karayekov, R. J. Staneloni, W. Gassmann, P. Mas, J. J. Casal, S. A. Kay, and M. J. Yanovsky
A Constitutive Shade-Avoidance Mutant Implicates TIR-NBS-LRR Proteins in Arabidopsis Photomorphogenic Development
PLANT CELL,
November 1, 2006;
18(11):
2919 - 2928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev.,
June 1, 2006;
58(2):
194 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ha, F. Hua, Y. Li, J. Ma, X. Gao, J. Kelley, A. Zhao, G. E. Haddad, D. L. Williams, I. W. Browder, et al.
Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H985 - H994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Emamaullee, R. V. Rajotte, P. Liston, R. G. Korneluk, J. R.T. Lakey, A.M. J. Shapiro, and J. F. Elliott
XIAP Overexpression in Human Islets Prevents Early Posttransplant Apoptosis and Reduces the Islet Mass Needed to Treat Diabetes
Diabetes,
September 1, 2005;
54(9):
2541 - 2548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Mathews, W. L. Suarez-Pinzon, J. J. Baust, K. Strynadka, E. H. Leiter, and A. Rabinovitch
Mechanisms Underlying Resistance of Pancreatic Islets from ALR/Lt Mice to Cytokine-Induced Destruction
J. Immunol.,
July 15, 2005;
175(2):
1248 - 1256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, J. Zienkiewicz, and J. Hawiger
Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1{beta} Signaling Pathway
J. Biol. Chem.,
July 15, 2005;
280(28):
26152 - 26159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Y. Jung, H. Lee, B.-Y. Jung, J. Ock, M.-S. Lee, W.-H. Lee, and K. Suk
TLR4, but Not TLR2, Signals Autoregulatory Apoptosis of Cultured Microglia: A Critical Role of IFN-{beta} as a Decision Maker
J. Immunol.,
May 15, 2005;
174(10):
6467 - 6476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zeender, K. Maedler, D. Bosco, T. Berney, M. Y. Donath, and P. A. Halban
Pioglitazone and Sodium Salicylate Protect Human {beta}-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1{beta}
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5059 - 5066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ruckdeschel, G. Pfaffinger, R. Haase, A. Sing, H. Weighardt, G. Hacker, B. Holzmann, and J. Heesemann
Signaling of Apoptosis through TLRs Critically Involves Toll/IL-1 Receptor Domain-Containing Adapter Inducing IFN-{beta}, but Not MyD88, in Bacteria-Infected Murine Macrophages
J. Immunol.,
September 1, 2004;
173(5):
3320 - 3328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. B. Joosten, M. I. Koenders, R. L. Smeets, M. Heuvelmans-Jacobs, M. M. A. Helsen, K. Takeda, S. Akira, E. Lubberts, F. A. J. van de Loo, and W. B. van den Berg
Toll-Like Receptor 2 Pathway Drives Streptococcal Cell Wall-Induced Joint Inflammation: Critical Role of Myeloid Differentiation Factor 88
J. Immunol.,
December 1, 2003;
171(11):
6145 - 6153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Scarim, S. Y. Nishimoto, S. M. Weber, and J. A. Corbett
Role for c-Jun N-Terminal Kinase in {beta}-Cell Recovery from Nitric Oxide-Mediated Damage
Endocrinology,
August 1, 2003;
144(8):
3415 - 3422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. Tran, G. Chen, C. B. Newgard, and H. E. Hohmeier
Discrete and Complementary Mechanisms of Protection of {beta}-Cells Against Cytokine-Induced and Oxidative Damage Achieved by bcl-2 Overexpression and a Cytokine Selection Strategy
Diabetes,
June 1, 2003;
52(6):
1423 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Thorens
cFLIP Protein Prevents Tumor Necrosis Factor-{alpha}-Mediated Induction of Caspase-8-Dependent Apoptosis in Insulin-Secreting {beta}Tc-Tet Cells
Diabetes,
June 1, 2002;
51(6):
1805 - 1814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Thorens
SOCS-1 Protein Prevents Janus Kinase/STAT-dependent Inhibition of beta Cell Insulin Gene Transcription and Secretion in Response to Interferon-gamma
J. Biol. Chem.,
July 6, 2001;
276(28):
25862 - 25870.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|